No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Drug Administration Schedule
-
Erythema / chemically induced
-
Follow-Up Studies
-
Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage
-
Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Middle Aged
-
Remission Induction
-
Rituximab / administration & dosage
-
Rituximab / adverse effects
-
Survival Analysis
-
Time Factors
-
Treatment Outcome
Substances
-
Rituximab
-
Granulocyte-Macrophage Colony-Stimulating Factor